Hypertrophic cardiomyopathy (HCM) is one of the most common genetic cardiovascular diseases, both in the US and globally. However, due to the wide variety of clinical symptoms that can be interpreted as other diseases, HCM patients often face misdiagnosis or treatment delays.
Hypertrophic cardiomyopathy is most often caused by abnormal genes in the heart muscle. These genes cause the walls of the heart chamber (left ventricle) to contract harder and become thicker than normal. The thickened walls become stiff
At the HCMA, our vision is to be the pre-eminent organization improving the lives of those with HCM, preventing untimely deaths, and advancing global understanding.